Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.
about
Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its managementInterfacial residues promote an optimal alignment of the catalytic center in human soluble guanylate cyclase: heterodimerization is required but not sufficient for activity.CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interestAmyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent mannerThrombospondin-1 mediates multi-walled carbon nanotube induced impairment of arteriolar dilationThrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.Aging of the nitric oxide system: are we as old as our NO?The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.Thrombospondin-1-Based Antiangiogenic Therapy.CD47 signaling pathways controlling cellular differentiation and responses to stress.Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activationThe role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertensionRegulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.Thrombospondins: old players, new gamesThrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.Thrombospondin-1, free radicals, and the coronary microcirculation: the aging conundrum.Regulation of cellular redox signaling by matricellular proteins in vascular biology, immunology, and cancerNitric oxide: what's new to NO?Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu.Physiological levels of thrombospondin-1 decrease NO-dependent vasodilation in coronary microvessels from aged rats.
P2860
Q24627155-6A337C3F-C082-4CAD-826A-443FB243CC5DQ26864499-682C0217-B8F1-419F-AEFB-FF860FF67A98Q27682500-B58706D1-2522-4341-AEFE-A86BBB16C894Q28270624-99E84094-618D-44A1-832C-E93F106482E7Q28476620-06B8E54B-91CA-44CB-B9C9-CECA03850E2BQ28917103-120BC672-AD16-4867-9A5C-A6575C9257F4Q30503997-C5DE1A5F-676B-499A-BCBC-FE51BEC0BFCBQ34075870-06346994-D500-4CFB-A12F-096631BE2E89Q34759986-9C97E781-FE08-467C-8374-18C06B70EF51Q35026305-A704F075-88EC-4D6A-8F19-0A4B3BA42855Q35429867-F455BD4E-C158-49C3-AED7-902496C9670DQ35809576-06C56EA3-AB83-4CCF-A834-1A69D4F97C80Q36417463-05475D71-0DD2-4E05-A30A-AFB5989CFF00Q36771076-B6FEE38F-C949-4892-AB8D-4C555D515FC1Q36997217-7943687D-F34F-4806-8BDA-EC08F27672E0Q37139980-AA72D6A1-B2E1-4FE5-B04C-A8D9C03CCDE1Q37697630-16AC8A18-233C-455D-B7EA-634390C695FAQ37963916-BD87044C-028B-4192-8333-5EE37E038DD7Q38124703-D8425550-00E9-4D70-A6E0-EE3EF247152BQ38177946-3DE03621-F1C7-46B2-A29C-FE0AEC3CD156Q38648723-FEAA7782-2B7E-4C07-9B6C-C05335214151Q38656989-5A7AF41B-29C9-462A-A462-7ADA0464A120Q39038560-22AD40B7-2886-4894-BCCA-DD14EBD5CFD4Q39284030-AC7F7A80-7271-48A4-8FF8-0598AD3CDED7Q46706302-0D382A36-39AC-4481-B9C3-B19790DF4E7FQ50896297-826EEEAB-1FD8-41B9-A385-B4BAEE86FB1A
P2860
Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@ast
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@en
type
label
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@ast
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@en
prefLabel
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@ast
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@en
P2093
P2860
P1476
Thrombospondin-1 is an inhibit ...... of soluble guanylate cyclase.
@en
P2093
David D Roberts
Jeff S Isenberg
Thomas W Miller
P2860
P304
P356
10.1111/J.1476-5381.2009.00631.X
P407
P577
2010-03-03T00:00:00Z